Editas Medicine to Present at Investor Conferences in May
May 08, 2017 20:02 pm UTC| Business
CAMBRIDGE, Mass., May 08, 2017 -- Editas Medicine, Inc. (NASDAQ:EDIT), a leading genome editing company, today announced that management will participate in two upcoming investor conferences in May. Details are as...
Editas Medicine to Present at Investor Conferences in May
May 08, 2017 20:02 pm UTC| Business
CAMBRIDGE, Mass., May 08, 2017 -- Editas Medicine, Inc. (NASDAQ:EDIT), a leading genome editing company, today announced that management will participate in two upcoming investor conferences in May. Details are as...
Achaogen Reports First Quarter 2017 Financial Results and Provides Corporate Update
May 08, 2017 20:02 pm UTC| Business
-- Presented additional Phase 3 EPIC and CARE trial data highlighting the safety and efficacy of plazomicin during late-breaker session at ECCMID -- -- Plazomicin registration activities on track; NDA submission planned...
Achaogen Reports First Quarter 2017 Financial Results and Provides Corporate Update
May 08, 2017 20:02 pm UTC| Business
-- Presented additional Phase 3 EPIC and CARE trial data highlighting the safety and efficacy of plazomicin during late-breaker session at ECCMID -- -- Plazomicin registration activities on track; NDA submission planned...
Editas Medicine to Host Conference Call Discussing First Quarter 2017 Corporate Update and Results
May 08, 2017 20:01 pm UTC| Business
CAMBRIDGE, Mass., May 08, 2017 -- Editas Medicine, Inc. (NASDAQ:EDIT), a leading genome editing company, today announced that it will host a conference call and webcast on Monday, May 15, 2017, at 5:00 p.m. ET to...
Fate Therapeutics to Webcast Conference Call Reporting First Quarter 2017 Financial Results
May 08, 2017 20:01 pm UTC| Business
SAN DIEGO, May 08, 2017 -- Fate Therapeutics, Inc. (NASDAQ:FATE), a clinical-stage biopharmaceutical company dedicated to the development of programmed cellular immunotherapies for cancer and immune disorders, announced...
Wall Street Journal Names Christopher Carduff Books Editor
May 08, 2017 20:01 pm UTC| Business
NEW YORK, May 08, 2017 -- The Wall Street Journal announced today the hiring of Christopher Carduff as Books Editor. He will be responsible for the daily book reviews as well as the collection of reviews in the weekend...
Threading Opportunity: How an India–EU FTA Could Reweave Textile Fortunes